UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Design of Phase 1/2a Study of AAV9-Based Gene Therapy for Parkinson’s Disease with Pathogenic GBA1 Mutations (PROPEL Trial) (1624)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Design and outcome measures for a phase 1/2 dose-finding study to evaluate systemic administration of an AAV9-based gene therapy for peripheral manifestations of Gaucher disease

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107239, Article 107239

2023

Volltextzugriff (PDF)

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial): Human/Trial design

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Volltextzugriff (PDF)

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial)

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

Phase 1/2 study update of an AAV9-based gene therapy for Gaucher disease type 2 (PROVIDE trial)

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107238, Article 107238

2023

Volltextzugriff (PDF)

Combination therapy for Alzheimer's disease: Are we ready?

Alzheimer's & dementia, 2018-09, Vol.14 (9), p.1232-1233

2018

Volltextzugriff (PDF)

S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S340-S341

2018

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

P1–359: A single ascending‐dose study of BIIB037 in people with mild‐to‐moderate Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_7), p.P290-P290

2013

Volltextzugriff (PDF)

A single ascending-dose study of BIIB037 in people with mild-to-moderate Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P290-P290

2013

Volltextzugriff (PDF)

Review: Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial

American journal of Alzheimer's disease and other dementias, 2010-03, Vol.25 (2), p.119-124

2010

Volltextzugriff (PDF)

Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S532-S532

2010

Volltextzugriff (PDF)

P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_17), p.S532-S532

2010

Volltextzugriff (PDF)

Meeting Report: Early risk assessment for Alzheimer's disease

Alzheimer's & dementia, 2009-03, Vol.5 (2), p.182-196

2009

Volltextzugriff (PDF)

21 - Infections of the Central Nervous System

On Call Neurology, p.294-314

Sevigny, Jeffrey Joseph

Volltextzugriff (PDF)

Axial MRI biomarkers of spinal cord damage to predict future walking and motor function: a retrospective study

Spinal cord, 2021-06, Vol.59 (6), p.693-699

2021

Volltextzugriff (PDF)

Predictive modeling of ambulatory outcomes after spinal cord injury using machine learning

Spinal cord, 2024-08, Vol.62 (8), p.446-453

2024

Volltextzugriff (PDF)

Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Communications biology, 2018-01, Vol.1 (1), p.112, Article 112

2018

Volltextzugriff (PDF)

Linking scores on the 4- and 5-item versions of the Satisfaction with Life Scale in people with traumatic brain, spinal cord, or burn injury: a National Institute on Disability, Independent Living, and Rehabilitation Research Model System study

Journal of patient-reported outcomes, 2021-07, Vol.5 (1), p.59-59, Article 59

2021

Volltextzugriff (PDF)

Response to Letter to the Editor on “A Single Dermatome Clinical Prediction Rule for Independent Walking One Year After Spinal Cord Injury”

Archives of physical medicine and rehabilitation, 2024-07, Vol.105 (7), p.1411-1412

2024

Volltextzugriff (PDF)

Venous thromboembolism: Exploring incidence and utility of screening in spinal cord injury

The journal of spinal cord medicine, 2023-05, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Volltextzugriff (PDF)

The influence of conventional T2 MRI indices in predicting who will walk outside one year after spinal cord injury

The journal of spinal cord medicine, 2023-05, Vol.46 (3), p.501-507

2023

Volltextzugriff (PDF)

Predicting outdoor walking one-year after spinal cord injury: a retrospective multisite external validation study

Journal of neurologic physical therapy, 2023-01, Vol.47 (3), p.155-161

2023

Volltextzugriff (PDF)

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

Frontiers in neurology, 2021-10, Vol.12, p.705407-705407

2021

Volltextzugriff (PDF)

Author Correction: Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Communications biology, 2018-12, Vol.1 (1), p.1-1, Article 237

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)
Buchkapitel
(1)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design of Phase 1/2a Study of AAV9-Based Gene Therapy for Parkinson’s Disease with Pathogenic GBA1 Mutations (PROPEL Trial) (1624)

Design and outcome measures for a phase 1/2 dose-finding study to evaluate systemic administration of an AAV9-based gene therapy for peripheral manifestations of Gaucher disease

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial): Human/Trial design

Design of a Phase 1/2 study of an AAV9‐based gene therapy for fronto‐temporal dementia patients with pathogenic GRN mutations (PROCLAIM trial)

Phase 1/2 study update of an AAV9-based gene therapy for Gaucher disease type 2 (PROVIDE trial)

Combination therapy for Alzheimer's disease: Are we ready?

S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG7203 IN PATIENTS WITH PROBING REWARD FUNCTIONS WITH IMAGING AND BEHAVIORAL APPROACHES

Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003)

P1–359: A single ascending‐dose study of BIIB037 in people with mild‐to‐moderate Alzheimer's disease

A single ascending-dose study of BIIB037 in people with mild-to-moderate Alzheimer's disease

Review: Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial

Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

P3‐275: Optimization of the treatment regimen with active Aß immunotherapy CAD106 in alzheimer patients

Meeting Report: Early risk assessment for Alzheimer's disease

21 - Infections of the Central Nervous System

Axial MRI biomarkers of spinal cord damage to predict future walking and motor function: a retrospective study

Predictive modeling of ambulatory outcomes after spinal cord injury using machine learning

Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Linking scores on the 4- and 5-item versions of the Satisfaction with Life Scale in people with traumatic brain, spinal cord, or burn injury: a National Institute on Disability, Independent Living, and Rehabilitation Research Model System study

Response to Letter to the Editor on “A Single Dermatome Clinical Prediction Rule for Independent Walking One Year After Spinal Cord Injury”

Venous thromboembolism: Exploring incidence and utility of screening in spinal cord injury

The influence of conventional T2 MRI indices in predicting who will walk outside one year after spinal cord injury

Predicting outdoor walking one-year after spinal cord injury: a retrospective multisite external validation study

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data

Author Correction: Biodiversity estimates and ecological interpretations of meiofaunal communities are biased by the taxonomic approach

Aktive Filter

Suchergebnisse filtern